Relevant bibliographies by topics / Endometroid Adenocarcinoma

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Endometroid Adenocarcinoma'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Endometroid Adenocarcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Endometroid Adenocarcinoma"

1

International, Journal of Medical Science and Innovative Research (IJMSIR). "A Big Lump in A Bump - Giant Endometroid Ovarian Adenocarcinoma – A Case Report." International Journal of Medical Science and Innovative Research (IJMSIR) 9, no. 4 (2024): 35–38. https://doi.org/10.5281/zenodo.15424243.

Full text
Abstract:
Endometroid carcinoma accounts for 10% of the ovarian cancer and it’s the second most common type of epithelial ovarian cancer. We hereby present a rare case of giant abdominopelvic mass that occurred in a 41 year old multiparous lady with retinitis pigmentosa which was assessed by ultrasound and Computed tomography. She underwent primary cytoreductive surgery with frozen section with bilateral pelvic lymph node dissection with infracolic omentectomy. In histopathology diagnosis of ovarian cancer with endometroid pattern was made. Diagnosis play an important role in detection, staging an
APA, Harvard, Vancouver, ISO, and other styles
2

Zivanovic, Aleksandar, Aleksandra Dimitrijevic, Tatjana Kastratovic, Janko Djuric, Vesna Stankovic, and Irena Tanaskovic. "Ovarian endometroid adenocarcinoma in pregnancy." Vojnosanitetski pregled 68, no. 2 (2011): 181–84. http://dx.doi.org/10.2298/vsp1102181z.

Full text
Abstract:
Background. Ovarian cancer is very rare in pregnancy. It is mainly of epithelial origin, low grade and low malignant potential. Case report. We presented a patient in which ultrasound confirmed the presence of clearly limited tumor in the left ovary when she was eight weeks pregnant. The results of 4D Color Doppler showed a central type of tumor vascularisation with resistance index (IR) less than 0.5. The Consultancy Board in Gynecology of the Institute for Oncology and Radiology of Serbia decided to remove the patient's left adnexa and intensively monitor the pregnancy period. The operation
APA, Harvard, Vancouver, ISO, and other styles
3

Catena, U., M. Mirandola, F. M. Capomacchia, F. Fanfani, and G. Scambia. "A new surgical approach for fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step-by-step technique." Facts, Views and Vision in ObGyn 15, no. 1 (2023): 79–81. http://dx.doi.org/10.52054/fvvo.15.1.058.

Full text
Abstract:
Background: 4% of endometrial cancers are diagnosed in young women and 70% are nulliparous. Preserve fertility in these patients is of major interest. It is demonstrated that hysteroscopic resection of focal well-differentiated endometrioid adenocarcinoma, followed by progestins achieve a complete response rate of 95.3%. Recently, fertility-sparing treatment was proposed also in case of moderately differentiated endometrioid tumors, with a relatively high remission rate. Objective: To show a new hysteroscopic approach, in case of fertility-sparing treatment of diffuse endometrial G2 endometrio
APA, Harvard, Vancouver, ISO, and other styles
4

Purandare, Nikhil C., Gillian Ryan, Fathl Ramli, Kara Purcell, Andrew Curtain, and Morgan McCourt. "Endometroid Adenocarcinoma: A Possibility after Hysterectomy." Journal of South Asian Federation of Obstetrics and Gynaecology 2, no. 3 (2010): 230–32. http://dx.doi.org/10.5005/jp-journals-10006-1108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Beresford-Cleary, N., S. Mehdi, and B. Magowan. "Femoral metastases from ovarian serous/endometroid adenocarcinoma." Journal of Surgical Case Reports 2012, no. 7 (2012): 9. http://dx.doi.org/10.1093/jscr/2012.7.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mahantshetty, Umesh, Aditi Aggarwal, Balasubramanium Ganesh, et al. "Clinical Outcome of Early-Stage Endometroid Adenocarcinoma." International Journal of Gynecological Cancer 23, no. 8 (2013): 1446–52. http://dx.doi.org/10.1097/igc.0b013e3182a2ff46.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kazmi, Alina, Noorin Zaidi, and Sumaiya Irfan. "Mixed cell adenocarcinoma of uterus: A case report." Indian Journal of Pathology and Oncology 10, no. 3 (2023): 288–90. http://dx.doi.org/10.18231/j.ijpo.2023.062.

Full text
Abstract:
Here we present a case of a 40-year old obese female admitted with the complaint of lower abdominal pain, pain during sexual intercourse and irregular menstruation. The transabdominal ultrasonography showed increased endometrial thickness. Histopathological examination showed (clear cell adenocarcinoma, endometroid carcinoma with squamous differentiation) mixed cell adenocarcinoma which is a very rare case.
APA, Harvard, Vancouver, ISO, and other styles
8

Hocker, Nathaniel, Maria Story, Alysa Lerud, and Sarat Kuppachi. "Severe hypercalcaemia from ectopic intact parathyroid hormone secretion treated with continuous renal replacement therapy in a patient with two malignancies." BMJ Case Reports 14, no. 6 (2021): e242172. http://dx.doi.org/10.1136/bcr-2021-242172.

Full text
Abstract:
We present a 61-year-old Caucasian woman with endometroid carcinoma as well as a poorly differentiated adenocarcinoma who developed severe hypercalcaemia in the setting of an elevated intact parathyroid hormone. The patient was hospitalised twice for her condition. During her first hospitalisation, she was diagnosed with an endometroid carcinoma and hypercalcaemia. With medical management, she had a normal calcium level on discharge. She presented 3 weeks later with hypercalcaemia and encephalopathy. This time her hypercalcaemia was refractory to medical management, and required continuous ren
APA, Harvard, Vancouver, ISO, and other styles
9

Bigsby, Glenn E., Robert W. Holloway, Burkhard Weppelman, Robert B. Reynolds, and Briana Williams. "Endometroid adenocarcinoma of the uterus with cardiac metastasis." Gynecologic Oncology 97, no. 1 (2005): 256–59. http://dx.doi.org/10.1016/j.ygyno.2004.12.052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Agrawal, Priti, Rishi Agrawal, Jaswant Jain, and Anandi Lobo. "Postmenopausal endometrial carcinoma presenting as urinary incontinence: a case report." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 6 (2021): 2544. http://dx.doi.org/10.18203/2320-1770.ijrcog20212215.

Full text
Abstract:
Endometrial carcinoma (EC) most commonly presents with postmenopausal bleeding (PMB) or blood tinged vaginal discharge. Watery vaginal discharge is usually reported in fallopian tube malignancy. We reported a case of EC where she had profuse watery discharge from private part mimicking urine and so patient visited urologist for urinary incontinence and was later diagnosed as endometroid adenocarcinoma. A 73 year old female presented with history of passing urine involuntarily for last 3 months. Endometrial biopsy revealed endometrial endometroid adenocarcinoma-FIGO grade-2. FDG PET-CT scan rev
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Endometroid Adenocarcinoma"

1

Bou, Serra José. "Estudio de los factores biológicos del adenocarcinoma de endometrio y su relación con la supervivencia." Doctoral thesis, Universitat de València, 2008. http://hdl.handle.net/10803/10151.

Full text
Abstract:
Introducción: Los factores pronósticos utilizados en el adenocarcinoma de endometrio para predecir el riesgo de recurrencia son los relacionados con el tipo de tumor (subtipo histológico y grado de diferenciación) y el estadio de diseminación. Otros factores de tipo molecular o biológico se han propuesto por algunos autores como factores pronósticos independientes de recurrencia y muerte por la enfermedad pero sin consenso entre todos los autores. Hipótesis: además de la existencia de factores quirúrgico-patológicos de reconocido valor pronóstico en el adenocarcinoma de endometrio, deben exist
APA, Harvard, Vancouver, ISO, and other styles
2

Tadini, Valdir. "Niveis plasmaticos de esteroides sexuais endogenos e gonadotrofinas em mulheres na pos-menopausa com e sem adenocarcinoma de endometrio." [s.n.], 1997. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313234.

Full text
Abstract:
Orientadores: Gustavo Antonio de Souza, Aarão Mendes Pinto Neto<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas<br>Made available in DSpace on 2018-07-22T22:05:44Z (GMT). No. of bitstreams: 1 Tadini_Valdir_M.pdf: 4201679 bytes, checksum: 943a5f093521fc5a3c4b8b2b87d30348 (MD5) Previous issue date: 1997<br>Resumo: O aumento da expectativa de vida neste final de século observado, principalmente na população feminina, tomou ainda mais importante o estudo de fatores predisponentes ao câncer genital feminino na pós-menopausa, e dentre eles, o câncer de
APA, Harvard, Vancouver, ISO, and other styles
3

Ko, Meng-Ting, and 柯孟廷. "Evaluation of the Roles of Ketohexokinase in Endometrioid Adenocarcinoma Progression." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/s7bn26.

Full text
Abstract:
碩士<br>國立臺灣大學<br>毒理學研究所<br>107<br>Ketohexokinase (KHK) is a rate-limiting enzyme of fructose metabolism. It can phosphorylate the fructose to generate fructose-1-phosphate which is the precursor of tricarboxylic acid cycle. However, it interested us that KHK-A isoform was discovered to induce cancer cell proliferation through nucleotide synthesis. As a result, we analyzed the correlation between KHK expression and patient survival in sixteen kinds of cancer type in clinical database and chose the endometrial cancer (EC) as our cancer model. The rising incidence of EC is too serious to ignore th
APA, Harvard, Vancouver, ISO, and other styles
4

Hu, Yu-Hao, and 胡毓豪. "Gene Methylation Profiles as Differentiating and Prognostic Markers in Ovarian Clear Cell Adenocarcinoma and Endometrioid Adenocarcinoma." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/62760693247050662136.

Full text
Abstract:
碩士<br>國立臺灣大學<br>分子醫學研究所<br>102<br>The purpose of the thesis was to investigate the methylation of various genes between patients with ovarian clear cell adenocarcinoma (OCCA) and ovarian endometrioid adenocarcinoma (OEA). In addition, we evaluated if methylation could be biomarkers in the chemo-response and outcome of the patients. The methylation statuses of eight candidate genes (RASSF1A, E-cadherin, DLEC1, RUNX3, SFRP1, SFRP5, PAX and LMX1A) were evaluated by methylation-specific polymerase chain reactions and capillary electrophoreses in 66 OCCA and 51 OEA patients. The clinico-pathologic
APA, Harvard, Vancouver, ISO, and other styles
5

"Functional characterization of YY1 and PCDH10 in human endometrioid endometrial Adenocarcinoma." 2012. http://library.cuhk.edu.hk/record=b5549492.

Full text
Abstract:
子宮内膜癌是最常见的妇科恶性肿瘤，其中有80%属于子宮内膜腺样癌，这一癌症发病的分子机制尚未清楚。研究表明，癌基因表达异常或者功能异常在肿瘤的发生发展过程中具有重要的作用。另一方面，抑癌基因在肿瘤细胞中特异性甲基化失活通常导致细胞恶性转变和肿瘤的发生。本实验将阐明癌基因阴阳1和抑癌基因PCDH10在人类子宮内膜腺样癌发病中的作用。<br>本实验第一部分研究多功能转录因子阴阳1（YY1）在子宮内膜腺样癌发病过程中的作用。首先本实验证实YY1在子宮内膜腺样癌临床标本和癌细胞系中均明显表达上调，并且上调的程度与肿瘤的FIGO分期相关。接着体外细胞培养和裸鼠荷瘤模型的实验均提示抑制YY1 表达可抑制癌细胞增殖和体外迁移，而过表达YY1则促进癌细胞增殖。这些结果表明YY1在子宮内膜腺样癌发病中具有促进作用。进一步全细胞基因组转录谱分析提示YY1 介入子宮内膜腺样发病的各个方面，并通过抑制抑癌基因APC的表达发挥发挥重要作用。深入的分子机制研究发现一个新的表观抑制作用模型：YY1可募集EZH2等多梳蛋白到APC启动子区并导致后者组蛋白3赖氨酸27上三甲基化，从而抑制APC基因转录。此外，本实验还发现YY1在子宮内膜腺样癌的表达增高是由于微小RNA，miR-193a-5p，在此癌中表达下降所导致的。所以，本实验第一部分的结果揭示了miR-193a-5p-YY1-APC这条全新的信号通路在子宮内膜
APA, Harvard, Vancouver, ISO, and other styles
6

Tang, Yu-Chien, and 唐語謙. "Correlation between PLOD2 expression level and the tumorigenesis and progression of endometrial endometrioid adenocarcinoma." Thesis, 2013. http://ndltd.ncl.edu.tw/handle/36117252119509442906.

Full text
Abstract:
碩士<br>國立臺灣大學<br>分子醫學研究所<br>101<br>Abstract OBJECTIVE: This study aimed to identify the dysregulated genes involved in the tumorigenesis and progression of endometrial endometrioid adenocarcinoma (EEC). METHODS: Specimens of endometrial tissues included 10 normal endometria (NEM), 10 atypical endometrial hyperplasia (AEH), and 85 EEC. The expression profiles were compared using GeneChip Array. The gene expression levels were determined by semi-quantitative reverse transcriptase PCR (SQ RT-PCR) in 16 samples and real-time reverse transcriptase PCR (RTQ RT-PCR) in 85 EEC patients. The correlation
APA, Harvard, Vancouver, ISO, and other styles
7

Lin, Hsiu-Ping, and 林秀萍. "CDO1 Gene Methylation as a Biomarker for Disease Severity and Outcome of Endometrioid Adenocarcinoma." Thesis, 2016. http://ndltd.ncl.edu.tw/handle/55512223567884364472.

Full text
Abstract:
碩士<br>國立臺灣大學<br>分子醫學研究所<br>104<br>The purpose of the study was to evaluate the levels of CDO1 promoter methylation between normal endometrium, atypical hyperplasia, and endometrioid adenocarcinoma. The relationship between the levels of CDO1 promoter methylation and the clinico-pathologic parameters of patients was also discussed. We aimed to investigate whether CDO1 gene methylation takes part in carcinogenesis and can be a biomarker for disease severity and outcome of endometrioid adenocarcinoma. Specimens of endometrial tissues include 6 normal endometrium, 4 atypical hyperplasia and 1
APA, Harvard, Vancouver, ISO, and other styles
8

Álvares, Cláudia Sofia Leitão. "Do endometrioma ao carcinoma do ovário - mecanismos biológicos." Master's thesis, 2021. http://hdl.handle.net/10316/98304.

Full text
Abstract:
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de Medicina<br>A possível transformação maligna que ocorre na endometriose está, à luz da evidência científica atual, maioritariamente limitada à endometriose ovárica, com origem em endometriomas. Estima-se que esta malignização ocorra em 0,3 a 1% dos casos de endometriose, ocorrendo 75% destes nos ovários. De facto, há um aumento da incidência de carcinoma do ovário nas mulheres com endometriose, os designados endometriosis-associated ovarian carcinomas (EAOC). Estes carcinomas são mais frequentemente dos subtipos carcin
APA, Harvard, Vancouver, ISO, and other styles
9

Pereira, Miguel Augusto Tavares. "Comparison of macrophages and lymphocytes in non-diseased endometrium and feline endometrial adenocarcinomas." Master's thesis, 2014. http://hdl.handle.net/10348/3147.

Full text
Abstract:
Dissertação de Mestrado Integrado em Medicina Veterinária, Ciências Veterinárias<br>Na gata, o útero é o órgão do trato genital onde ocorrem com maior frequência tumores, embora contribua apenas com 0,29% para todos os tumores diagnosticados nesta espécie animal. Apesar de ser considerado um tumor raro, vários estudos têm mostrado a possibilidade do adenocarcinoma do endometrio felino (FEA) poder ser mais frequente do que se pensava inicialmente. Conscientes da importância do sistema imunitário, através de uma relação dinâmica, na imunoedição dos tumores, este estudo teve por objetivo a avalia
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Endometroid Adenocarcinoma"

1

Cook, Linda S., Angela L. W. Meisner, and Noel S. Weiss. Endometrial Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0047.

Full text
Abstract:
Endometrial cancer is rare among women of reproductive age, but in older women can occur at an annual rate of up to 50 –100 per 100,000. The incidence varies more than five-fold across regions of the world, with the rates generally being highest in North America and Europe. Endometrial cancer can be classified into two broad histologic groups: the more common type I tumors (e.g., endometrioid adenocarcinoma), which have a relatively good prognosis (case-fatality in the neighborhood of 20%); and the less common type II tumors (e.g., serous carcinoma), which have a poorer prognosis. The endometr
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Endometroid Adenocarcinoma"

1

Ma, Fenghua. "Ovarian Endometrioid Adenocarcinoma." In MRI of Gynaecological Diseases. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-3644-1_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kurnit, Katherine C., Bojana Djordjevic, and Russell R. Broaddus. "Molecular Pathology of Endometrioid Adenocarcinoma." In Molecular Pathology Library. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57985-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jeffus, Susanne K., and Charles M. Quick. "Precancerous Lesions of Endometrioid Adenocarcinoma." In Precancerous Lesions of the Gynecologic Tract. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-22509-8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bazot, Marc, Isabelle Thomassin-Naggara, and Emile Daraï. "CT and MR Imaging of Ovarian Adenocarcinoma (Serous/Mucinous/Endometrioid)." In Ovarian Neoplasm Imaging. Springer US, 2013. http://dx.doi.org/10.1007/978-1-4614-8633-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Watson, Dr Max, Ann Barrett, Roy AJ Spence, and Chris Twelves. "Patients with common gynaecological cancers." In Oncology. Oxford University PressOxford, 2006. http://dx.doi.org/10.1093/oso/9780198567578.003.0011.

Full text
Abstract:
Abstract In 2001 6,883 women were diagnosed with ovarian cancer in the UK.1 In 2003 4,617 women died from ovarian cancer in the UK.2 Background *Fifth commonest cancer in women *Commonest gynaecological cancer in the UK *Risk is reduced by factors that reduce the number of ovulatory cycles, e.g. pregnancy, prolonged use of oral contraceptive pill * *Median age at diagnosis 66 years *&amp;gt; 90% of tumours are epithelial in origin . Serous adenocarcinoma 40–50% . Endometrioid 15–30% . Mucinoid and clear cell 10–15% each *Spread is predominantly to other organs in the pelvic cavity and is often
APA, Harvard, Vancouver, ISO, and other styles
6

Trombetta, Giulia, Monica Della Martina, Martina Venier, and Angelo Cagnacci. "Hormonal Replacement Therapy After Neoplasia Treatment." In NEOPLASIA and FERTILITY. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815050141122010012.

Full text
Abstract:
Post-menopausal hormonal therapy (HT) may help to improve quality of life and prevent long-term consequences of estrogen deficiency. The use of HT in postmenopausal cancer survivors is controversial, particularly for those women having survived hormone-dependent tumors, like breast or gynecological cancers. Endometrial cancer is the most frequent gynecological cancer. The limited data of the literature on women having suffered from endometrial cancer do not show an increased recurrence or death with HT use, but guidelines do not yet indicate the generalized use of HT in these women. HT should
APA, Harvard, Vancouver, ISO, and other styles
7

Vicuña, Vinicius Humberto de Souza, and Ketheryn Adna Souza de Almeida. "ADENOCARCINOMA ENDOMETRIOIDE SOBRE FOCO DE ENDOMETRIOSE NA PAREDE ABDOMINAL: RELATO DE CASO CLÍNICO E REVISÃO DE LITERATURA." In Medicina: Longe dos holofotes, perto das pessoas 2. Atena Editora, 2021. http://dx.doi.org/10.22533/at.ed.6382108102.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Endometroid Adenocarcinoma"

1

Donabedian, P. L., K. Ray, C. Witten, et al. "Abdominal Compartment Syndrome Caused by Massive Cystic Endometroid Adenocarcinoma." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7323.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shukr, Ghadear, Tra Pham, and Thomas Buekers. "Abstract 3344: Effect of anticoagulation on the cancer stage at time of diagnosis of endometroid adenocarcinoma in a cohort of postmenopausal patients." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-3344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shukr, Ghadear, Tra Pham, and Thomas Buekers. "Abstract 3344: Effect of anticoagulation on the cancer stage at time of diagnosis of endometroid adenocarcinoma in a cohort of postmenopausal patients." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-3344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Luis Carballo García, Antonio, Álvaro García Aguilera, Ana Cristina Fernández Rísquez, Jesús Carlos Presa Lorite, and Jesús Joaquín Hijona Elósegui. "1077 Colorectal adenocarcinoma with endometrioid histology." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jain, Nidhi, Rahul Manchanda, Anshika Lekhi, Sravani Chithra, and Hena Kausar. "Primary clear cell adenocarcinoma of cervix in a young women: A rare entity." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685279.

Full text
Abstract:
Cervical cancer is the most common gynaecological malignancy worldwide. The most common type of cervical carcinoma is squamous cell carcinoma followed by adenocarcinoma of cervix, which constitutes only 15% of cases. Adenocarcinoma of cervix can be categorized histologically into clear cell, mucinous, endometrioid, serous and mesonephric subtypes. Clear cell adenocarcinoma (CCA) most commonly occurs in the ovary, followed by endometrium, vagina, and cervix. Primary CCA of cervix is a rare neoplastic entity, which occurs in young women exposed to diethylstilbestrol (DES) in utero. It is extreme
APA, Harvard, Vancouver, ISO, and other styles
6

Szeterlak, N., M. Beer, M. Hamann, and M. Pölcher. "Endometrioid adenocarcinoma arising in adenomyosis – difficulties in diagnostics." In 62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe – DGGG'18. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1671340.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Devor, Eric J., Michael Goodheart, Koenraad DeGeest, David Bender, Thomas Buekers, and Kimberly K. Leslie. "Abstract 3040: Differential microRNA expression between normal edometrium, endometrioid adenocarcinoma, papillary serous adenocarcinoma, and carcinosarcoma." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brincat, Mark, Tiffany Buhagiar, Sharon Falzon, et al. "597 Mismatch repair protein expression defects in endometrioid endometrial adenocarcinoma." In ESGO SoA 2020 Conference Abstracts. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/ijgc-2020-esgo.214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tay, Liza, Adele Wong, Hoon Seng Khoo Tan, and Felicia Chin. "89 Primary endometrioid adenocarcinoma of the cervix: a diagnostic dilemma." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.131.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bastos, Alberto Freaza Lobão, Paula de de Holanda, José Augusto Machado, Nereu Guerra Neto, Amanda Mendes Soares, and Yara Lúcia Mendes Furtado de Melo. "O uso da imuno-histoquímica no diagnóstico diferencial do adenocarcinoma endometrial: relato de caso." In 44° Congresso da SGORJ - XXIII Trocando Ideias. Zeppelini Editorial e Comunicação, 2020. http://dx.doi.org/10.5327/jbg-0368-1416-2020130202.

Full text
Abstract:
Introdução: O câncer de corpo uterino é um dos tumores ginecológicos mais prevalentes na pós-menopausa, sendo o adenocarcinoma o mais frequente. Em alguns casos, o sítio primário, endométrio ou colo uterino, só pode ser definido pela imuno-histoquímica. Objetivo: Relatar caso de adenocarcinoma de endométrio de conclusão diagnóstica com estudo imuno-histoquímico. Relato de Caso: Paciente de 48 anos, G IV P III, índice de massa corpórea (IMC) 21 kg/m2, vem encaminhada pela Clínica da Família em razão de pólipo em colo uterino. Referia sangramento transvaginal contínuo e discreto, dispareunia, co
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Endometroid Adenocarcinoma' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography